SCHEMBL1924917

SCHEMBL1924917

CC(=O)n1ccc(=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.62
POLB P06746 3/20 0.50
CREBBP Q92793 3/20 0.47
BRPF1 P55201 1/20 0.47
BRD9 Q9H8M2 1/20 0.47
HTT P42858 2/20 0.45
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
MAPT P10636 2/20 0.43
PAX8 Q06710 1/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28220534 0.85 NOTUM (0.45) NOTUMPOLBCREBBPBRPF1BRD9
SCHEMBL28220514 0.84 NOTUM (0.44) NOTUMPOLBCREBBPBRPF1BRD9
SCHEMBL6593785 0.83 NOTUM (0.42) NOTUMPOLBALDH1A1SMN1; SMN2KDM4E
SCHEMBL608411 0.82 NOTUM (0.43) NOTUMPOLBCREBBPKMT2AALDH1A1
SCHEMBL9060883 0.81 NOTUM (0.41) NOTUMPOLBHTTKMT2AALDH1A1
SCHEMBL24476978 0.77 L3MBTL1 (0.51) NOTUMCREBBPKMT2AMEN1
SCHEMBL41252 0.75 NOTUM (1.00) NOTUMPOLBKMT2AALDH1A1KDM4E
SCHEMBL29506395 0.75 NOTUM (1.00) NOTUMPOLBKMT2AALDH1A1KDM4E
SCHEMBL11573644 0.74 NOTUM (0.67) NOTUMPOLBCREBBPBRPF1BRD9
SCHEMBL29037094 0.74 NOTUM (0.62) NOTUMPOLBCREBBPBRPF1BRD9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064185-B1 1H-QUINOLIN-4-ONE COMPOUNDS, WITH AFFINITY FOR THE GABA RECEPTOR, PROCESSES, USES AND COMPOSITIONS FERRER INT (ES) 2011-06-08 EP disclosed
US-20100168099-A1 1H-QUINOLIN-4-ONE COMPOUNDS, WITH AFFINITY FOR THE GABA RECEPTOR, PROCESSES, USES AND COMPOSITIONS FERRER INTERNACIONAL, S.A. (ES) 2010-07-01 US disclosed
EP-1886996-A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions FERRER INTERNACIONAL, S.A. (ES) 2008-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168099-A1 1H-QUINOLIN-4-ONE COMPOUNDS, WITH AFFINITY FOR THE GABA RECEPTOR, PROCESSES, USES AND COMPOSITIONS GABRA1, GABRA4, GABRA2 NOTUM 4676/4885POLB 3884/4885CREBBP 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.